Arkadios Wealth Advisors Sells 4,649 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Arkadios Wealth Advisors decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 36.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,107 shares of the healthcare conglomerate’s stock after selling 4,649 shares during the quarter. Arkadios Wealth Advisors’ holdings in UnitedHealth Group were worth $4,298,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in UNH. CoreCap Advisors LLC increased its position in UnitedHealth Group by 0.5% during the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock worth $2,166,000 after buying an additional 19 shares during the last quarter. Elgethun Capital Management increased its position in UnitedHealth Group by 0.3% during the second quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock worth $3,369,000 after buying an additional 19 shares during the last quarter. Hollencrest Capital Management grew its position in shares of UnitedHealth Group by 0.8% in the third quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock valued at $1,180,000 after purchasing an additional 19 shares during the last quarter. Smith Salley & Associates grew its position in shares of UnitedHealth Group by 0.7% in the third quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock valued at $1,451,000 after purchasing an additional 19 shares during the last quarter. Finally, MFA Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 4.8% in the third quarter. MFA Wealth Advisors LLC now owns 414 shares of the healthcare conglomerate’s stock valued at $209,000 after buying an additional 19 shares during the period. Institutional investors own 86.31% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $469.50 on Friday. The company has a market capitalization of $437.97 billion, a price-to-earnings ratio of 22.16, a PEG ratio of 1.32 and a beta of 0.69. UnitedHealth Group Incorporated has a twelve month low of $449.70 and a twelve month high of $558.10. The stock has a fifty day simple moving average of $483.26 and a 200 day simple moving average of $510.69. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, beating analysts’ consensus estimates of $5.17 by $0.17. The business had revenue of $82.79 billion during the quarter, compared to the consensus estimate of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the business posted $4.48 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 24.91 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 21st. Shareholders of record on Monday, March 13th will be issued a dividend of $1.65 per share. The ex-dividend date is Friday, March 10th. This represents a $6.60 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s payout ratio is currently 31.15%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $615.00 to $617.00 and gave the company a “buy” rating in a research note on Tuesday, January 24th. Credit Suisse Group boosted their price target on UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, December 7th. Morgan Stanley reiterated an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. Stephens restated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research note on Tuesday, February 28th. Finally, StockNews.com upgraded UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 11th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $599.68.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.